Factor-XIII activity in patients with mild to moderate ulcerative colitis and active bleeding: a prospective observational study

Abstract Objective Coagulation factor XIII plays a key role in fibrin clot stabilization and epithelial healing. Under chronic inflammatory conditions involving bleeding and an activation of the coagulation cascade, the FXIIIa inversely correlate with disease activity. We assumed that FXIIIa could b...

Full description

Bibliographic Details
Main Authors: Karsten Bernerth, Ingolf Schiefke, Karin Liebscher, Susanne Raczynski, Tanja Kottmann, Niels Teich
Format: Article
Language:English
Published: BMC 2018-12-01
Series:BMC Research Notes
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13104-018-3963-8
id doaj-8f5abe2baa9649c1a223bda34d5f3e1a
record_format Article
spelling doaj-8f5abe2baa9649c1a223bda34d5f3e1a2020-11-24T21:57:28ZengBMCBMC Research Notes1756-05002018-12-011111510.1186/s13104-018-3963-8Factor-XIII activity in patients with mild to moderate ulcerative colitis and active bleeding: a prospective observational studyKarsten Bernerth0Ingolf Schiefke1Karin Liebscher2Susanne Raczynski3Tanja Kottmann4Niels Teich5Practice for Internal MedicineDepartment of Gastroenterology Hepatology, Endocrinology, and Diabetology, Leipzig, Klinikum St. Georg gGmbHInstitute of Transfusion Medicine and Clinical Hemostasis, Klinikum St. Georg gGmbHPractice for GastroenterologyClinical Research Organization Dr. med KottmannPractice for Digestive and Metabolic DiseasesAbstract Objective Coagulation factor XIII plays a key role in fibrin clot stabilization and epithelial healing. Under chronic inflammatory conditions involving bleeding and an activation of the coagulation cascade, the FXIIIa inversely correlate with disease activity. We assumed that FXIIIa could be a predictor of severity in patients with ulcerative colitis (UC). Here, we evaluated the course of plasma activity of FXIIIa in 49 patients with mild to moderate UC and active rectal bleeding. Patients with a partial Mayo bleeding subscore > 2 were eligible to participate in our prospective observational study in an outpatient setting. FXIIIa was investigated during acute flare conditions, after bleeding had stopped and later on in quiescent UC. Results Plasma activity of FXIIIa did not show any significant differences during the UC course. FXIIIa was measured below normal range < 70% in only 8 patients during the flare and increased to normal values during follow-up in 7 of these patients. Low FXIIIa during the flare was not associated with an increased bleeding activity. In patients with a mild to moderate UC flare and prolonged bleeding, FXIIIa activity is neither predictive of UC severity nor of any bleeding activity in an outpatient setting. Trial registration This non interventional, non pharmacological prospective study was not obligated to receive a unique identifying number. This trial is registered with the Ethics Committee of the State Medical Chamber of Saxony, Dresden, Germany (Clinical Trials Registry number EK-BR-03/14-1)http://link.springer.com/article/10.1186/s13104-018-3963-8Factor-XIII activityUlcerative colitisInflammatory bowel disease
collection DOAJ
language English
format Article
sources DOAJ
author Karsten Bernerth
Ingolf Schiefke
Karin Liebscher
Susanne Raczynski
Tanja Kottmann
Niels Teich
spellingShingle Karsten Bernerth
Ingolf Schiefke
Karin Liebscher
Susanne Raczynski
Tanja Kottmann
Niels Teich
Factor-XIII activity in patients with mild to moderate ulcerative colitis and active bleeding: a prospective observational study
BMC Research Notes
Factor-XIII activity
Ulcerative colitis
Inflammatory bowel disease
author_facet Karsten Bernerth
Ingolf Schiefke
Karin Liebscher
Susanne Raczynski
Tanja Kottmann
Niels Teich
author_sort Karsten Bernerth
title Factor-XIII activity in patients with mild to moderate ulcerative colitis and active bleeding: a prospective observational study
title_short Factor-XIII activity in patients with mild to moderate ulcerative colitis and active bleeding: a prospective observational study
title_full Factor-XIII activity in patients with mild to moderate ulcerative colitis and active bleeding: a prospective observational study
title_fullStr Factor-XIII activity in patients with mild to moderate ulcerative colitis and active bleeding: a prospective observational study
title_full_unstemmed Factor-XIII activity in patients with mild to moderate ulcerative colitis and active bleeding: a prospective observational study
title_sort factor-xiii activity in patients with mild to moderate ulcerative colitis and active bleeding: a prospective observational study
publisher BMC
series BMC Research Notes
issn 1756-0500
publishDate 2018-12-01
description Abstract Objective Coagulation factor XIII plays a key role in fibrin clot stabilization and epithelial healing. Under chronic inflammatory conditions involving bleeding and an activation of the coagulation cascade, the FXIIIa inversely correlate with disease activity. We assumed that FXIIIa could be a predictor of severity in patients with ulcerative colitis (UC). Here, we evaluated the course of plasma activity of FXIIIa in 49 patients with mild to moderate UC and active rectal bleeding. Patients with a partial Mayo bleeding subscore > 2 were eligible to participate in our prospective observational study in an outpatient setting. FXIIIa was investigated during acute flare conditions, after bleeding had stopped and later on in quiescent UC. Results Plasma activity of FXIIIa did not show any significant differences during the UC course. FXIIIa was measured below normal range < 70% in only 8 patients during the flare and increased to normal values during follow-up in 7 of these patients. Low FXIIIa during the flare was not associated with an increased bleeding activity. In patients with a mild to moderate UC flare and prolonged bleeding, FXIIIa activity is neither predictive of UC severity nor of any bleeding activity in an outpatient setting. Trial registration This non interventional, non pharmacological prospective study was not obligated to receive a unique identifying number. This trial is registered with the Ethics Committee of the State Medical Chamber of Saxony, Dresden, Germany (Clinical Trials Registry number EK-BR-03/14-1)
topic Factor-XIII activity
Ulcerative colitis
Inflammatory bowel disease
url http://link.springer.com/article/10.1186/s13104-018-3963-8
work_keys_str_mv AT karstenbernerth factorxiiiactivityinpatientswithmildtomoderateulcerativecolitisandactivebleedingaprospectiveobservationalstudy
AT ingolfschiefke factorxiiiactivityinpatientswithmildtomoderateulcerativecolitisandactivebleedingaprospectiveobservationalstudy
AT karinliebscher factorxiiiactivityinpatientswithmildtomoderateulcerativecolitisandactivebleedingaprospectiveobservationalstudy
AT susanneraczynski factorxiiiactivityinpatientswithmildtomoderateulcerativecolitisandactivebleedingaprospectiveobservationalstudy
AT tanjakottmann factorxiiiactivityinpatientswithmildtomoderateulcerativecolitisandactivebleedingaprospectiveobservationalstudy
AT nielsteich factorxiiiactivityinpatientswithmildtomoderateulcerativecolitisandactivebleedingaprospectiveobservationalstudy
_version_ 1725855370787684352